Obsidio Conformable Embolic, Material Numbers (UPN): a) M0013972001010, b) M0013972101010
Published April 3, 2024 · Recall initiated: February 20, 2024
Summary
FDA records medical device Class I recall Z-1374-2024, published April 3, 2024 and initiated February 20, 2024. Recalling firm: Boston Scientific Corporation; Status: Ongoing; Reported quantity: 985 units; Lot: a) M0013972001010, UDI/DI 00191506039332, ALL LOT CODES b) M0013972101010, UDI/DI 00191506043124, ALL LOT CODES. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
An investigation determined that delivery of the Obsidio embolic using the aliquot technique for lower gastrointestinal bleeding embolization poses a high risk of bowel ischemia. The most serious and the most common adverse health consequence, reasonably foreseeable to occur, is the need to perform major surgery such as bowel resection and/or diverting colostomy. Therefore, Boston Scientific does not recommend that the aliquot technique be used to deliver the Obsidio device for lower GI bleed embolization procedures.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boston Scientific Corporation
- Distributor
- US
- Lot
- a) M0013972001010, UDI/DI 00191506039332, ALL LOT CODES b) M0013972101010, UDI/DI 00191506043124, ALL LOT CODES
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDANaviFlex LW Pusher; Advx Panc. Stent 4/5F; Material Number (UPN): M00535030;October 21, 2026
- FDAImager II Angiographic Catheters M001314001 IMAGER II/5/ST/65/038 BX5; M001314011 IMAGER II/5/ST/100/038 BX5;September 30, 2026
- FDABoston Scientific Corporation StoneSmart Connect Console Contents: (1) Power Cord, (1) Power Adaptor, (1)DVISeptember 23, 2026
- FDALUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS US, Model NumberSeptember 9, 2026
- FDAVITROS Performance Verifier IIApril 3, 2024
- FDAInsufflation unit, UHI-4.April 3, 2024
Questions about this recall
Was Obsidio Conformable Embolic, Material Numbers (UPN): a) M0013972001010, b) M0013972101010 recalled?
Yes. FDA published recall Z-1374-2024 on April 3, 2024. Reported hazard: An investigation determined that delivery of the Obsidio embolic using the aliquot technique for lower gastrointestinal bleeding embolization poses a high risk of bowel ischemia. The most serious and the most common adverse health consequence, reasonably foreseeable to occur, is the need to perform major surgery such as bowel resection and/or diverting colostomy. Therefore, Boston Scientific does not recommend that the aliquot technique be used to deliver the Obsidio device for lower GI bleed embolization procedures.
What should I do if I have this product?
Voluntary: Firm initiated · Letter